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Increased prevalence of antimicrobials resistance 
of pathogenic bacteria is a growing world wide 
concern. Its major risk factor has been generally 
considered as a consequence of the wide use of 
antimicrobials leading to the emergence and 
dissemination of resistant bacteria and resistance 
genes (van den Bogaard and Stobberingh, 2000). 
Pet animals, especially dogs, represent potential 
sources for the spreading of antimicrobial 
resistance resulting from the extensive use of 
antimicrobial agents in these animals and their 
close contact with humans (Guardabassi et al., 
2004). Reports of extra-intestinal infections in 
dogs due to multidrug-resistant Escherichia coli 
(MDREC) strains, resistant to third-generation 
cephalosporins and fluoroquinolones, have 
aroused special concern (Warren et al., 2001; 
Sanchez et al., 2002). Canine MDREC have been 
shown to harbor class 1 integron-associated 
resistance genes that had been identified in 
bacteria isolated from human clinical infections 
suggesting the spread of resistance mechanisms 
from canine to human bacteria, possibly via co-
selection and transfer of multidrug resistance 
plasmids (Kang et al., 2005). Although the 
transfer of integrons between human and animal 
bacterial strains has not been fully explained, it 
is known that resistance to antimicrobial agent 
can spread from animals to humans via 
transferable plasmids (Winokur et al., 2001).  
  
An emerging pathogen, Shiga toxin-producing E. 
coli (STEC) of the O157:H7 serotype, has been 
considered to be responsible for many outbreaks 
of hemorrhagic colitis and the hemolytic uremia 
syndrome in humans (Caprioli et al., 2005). 
However, other E. coli serogroups, known to be 
non-O157, are also important and prevalent in 
animals, suggesting that humans may also be 
exposed to them (Blanco et al., 2004). Two types 
of Shiga toxins, known as stx 1 and stx 2, 
constitute the main virulence factor in STEC 
strains (Law, 2000), commonly isolated from the 
feces of ruminants, like cattle and sheep (Kudva 
et al., 1997; Rigobelo et al., 2006), and 
occasionally from pigs (Macedo et al., 2007). 
Dogs have also been found to carry STEC 
strains, but their role as bacterial reservoirs has 
not been totally elucidated (Bentancor et al., 
2007). The prevalence of STEC strains among 
intestinal bacterial strains has been shown to be 
of highly variable occurrence (Bentancor et al., 
2007).  
  
The use of antimicrobial drugs for diarrhea 
treatment remains questionable, in special when 
STEC strains are involved; nevertheless, 
intensive use of antimicrobial drugs in pets has 
been well documented (Guardabassi et al., 
2004). Dogs that carry MDREC in their feces 
may readily contaminate the environment and are 
potential sources for the transmission of these 
bacteria to other animals and to humans (Warren 
et al., 2001). Thus, it was the aim of the present 
work, to study the occurrence of STEC strains in 
diarrheic dogs, and to examine their 
susceptibility to 11 antimicrobial agents, to 
verify their multidrug resistance patterns, and to 
assess their significance as sources of infection. 
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From January to December of 2006, 25 diarrheic 
dogs were examined after their arrival for 
consultation at a private clinic in the city of 
Ituverava, SP, Brazil. Samples collected by rectal 
swabbing, under the supervision of a 
veterinarian, were placed in a Stuart transport 
medium and taken to a laboratory for immediate 
processing. They were transferred to MacConkey 
agar1, and incubated for 24h at 37ºC. At least 
five randomly chosen colonies from each plate 
were selected for analysis. Biochemical 
confirmation of the strains as E. coli was 
performed according to Koneman et al. (1997). 
Bacteria overnight grown in nutrient broth2 at 
37ºC were tested for the presence of stx genes 
(stx 1 and stx 2), using the polymerase chain 
reaction (PCR) protocol of Orden et al. (1998). 
DNA templates were prepared from bacterial 
cells, resuspended in sterile distilled water, and 
boiled at 100ºC for 10min. Reference E. coli 
strains used as controls were EDL 933 
(O157:H7, stx1, stx 2,and eae); DH5α was used 
as the negative control. STEC samples were 
typed for the serotype O157 using the O157 
latex agglutination test kit3. Negative strains on 
agglutination were considered non-O157 strains. 
 
Antimicrobial disk susceptibility tests were 
performed using the disk diffusion method, 
recommended by the NCCLS (Performance…, 
2002). Drug-impregnated disks4 were placed on 
the surface of the agar using a disk dispenser. 
 
The following 11 antimicrobial agents were 
tested for bacterial resistance: ampicillin, 
amoxicillin, amoxicillin/clavulanic acid, 
amikacin, cephalothin, gentamicin, tetracycline, 
streptomycin, nalidixic acid, cotrimoxazole, and 
ciprofloxacin. 
 
A total of 92 E. coli strains were isolated from 
the 25 diarrheic dogs, and all of them were 
investigated by PCR for the presence of Shiga 
toxin-producing genes (stx 1 and stx 2). Table 1 
shows that 12 (13.0%) of the strains carried the 
stx gene; seven (7.6%) carried only the stx 1 
gene, five (5.4%) the stx 2 gene, and none 
carried both genes. All STEC isolated strains 
were tested by the O157 latex agglutination test 
kit; no O157 was detected in the isolated strains. 
The occurrence of stx genes (40.0%) among E. 
coli samples from diarrheic animals in the 
present study agrees with the results on the same 
subject reported by Hammermuler et al. (1995), 
i.e 44.4%, as well as the presence of stx 1 or stx 
2 genes among STEC strains, but not of both of 
them together. However, it is noteworthy that 
Nakazato et al. (2004), in Brazil, did not find 
STEC strains carrying stx 1 or stx 2 genes among 
146 diarrheic and 36 healthy dogs examined. 
  
  
Table 1. Distribution of Shiga toxin genes and resistance pattern of strain of Shiga- toxin-producing 
Escherichia coli from twenty-five diarrheic dogs in Ituverava, São Paulo 
Strain* Genetic marker Resistance pattern 
10.3 stx 1 AMP, AMO, AMC, CFL, GEN, STR, AMK, NAL, SUT 
20.2 stx 1 AMP, AMO, CFL, GEN, STR, SUT 
36.4 stx 2 AMP, AMO, CFL, TET, GEN, STR, SUT 
37.2 stx 1 CFL, TET, STR 
39.4 stx 1 AMP, CFL, TET, GEN, STR 
44.3 stx 2 AMP, AMO 
46.1 stx 2 CFL, TET, GEN, STR, AMK 
47.3 stx 2 AMP, AMO, CFL, TET, GEN, STR, NAL, CIP 
47.4 stx 1 AMO 
48.3 stx 2 AMP, CFL, GEN, STR, AMK, NAL, CIP 
                                                 
 1Mac-Difco- Difco - USA. 
2Sigma Chemical Co - St Louis, USA. 
3Oxoid, Basingstoke - Hampshire, UK. 
4CEFAR - São Paulo, Brazil. 
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51.3 stx 1 CFL, NAL 
51.4 stx 1 STR 
*Number of the strains. AMP: ampicillin; AMO: amoxicillin; AMC: amoxicillin/clavulanic acid; CFL: cephalothin; 
GEN: gentamicin; STR: streptomycin; AMK: amikacin; NAL: nalidixic acid; SUT: cotrimoxazole; TET: 
tetracycline; CIP: ciprofloxacin. 
 
The existence of multidrug-resistant phenotypes 
among bacteria housed by animals has been a 
cause of concern to veterinarians. Sanchez et al. 
(2002) reported the isolation of E. coli resistant 
to 12 antimicrobial drugs from two dogs; and 
Warren et al. (2001), the isolation of 18 
multidrug-resistant E. coli strains from 10 dogs 
in Australia; all showed an extended spectrum of 
β lactamase activity. Normand et al. (2000) 
reported that 30% of the E. coli samples isolated 
from dogs that they examined in England were 
multidrug-resistant; however, all of them did not 
work with STEC strains.  
 
In the present work, among the 12 STEC isolated 
samples examined, seven (58%) presented a 
MDREC phenotype resistant to four or more 
antimicrobial drugs, although it is not common 
for STEC strains to exhibit resistance to several 
antimicrobial drugs (Bettelheim et al., 2003). 
However, Cergole-Novella et al. (2006) also 
reported the isolation of STEC strains from 
humans and from bovine species in Brazil 
showing resistance to five or six antimicrobial 
drugs.  
 
The carrying of MDREC organisms by dogs 
represents a potential hazard for people having 
contact with such animals, running the risk of 
spreading resistance genes. In the present study, 
results showing a high percentage of STEC 
strains isolated from diarrheic dogs, presenting a 
multidrug-resistance phenotype, give rise to 
considerable concern and suggest that 
monitoring of the extent of this problem is an 
advisable measure.  
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RESUMO 
 
Noventa e duas amostras de Escherichia coli, isoladas de 25 cães diarreicos, em Ituverava, SP, foram 
examinadas para a detecção dos genes codificadores de Shiga toxinas (stx 1 e stx 2). Por meio da 
reação em cadeia da polimerase, foram identificadas sete amostras positivas para o gene stx 1 e cinco 
para o gene stx 2, não foi detectada nenhuma amostra com os dois genes. As 12 amostras que 
apresentavam genes codificadores de Shiga toxinas (stx 1 e stx), foram testadas frente a 11 agentes 
antimicrobianos, sendo que sete delas (58,0%) apresentaram resistência a múltiplas drogas, o que 
representa um motivo de preocupação. 
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